22nd Century Announces $3.0 Million Registered Direct Offering Priced Above Market
06. Juli 2023 09:25 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., July 06, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...
22nd Century Announces 1-for-15 Reverse Stock Split
03. Juli 2023 06:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., July 03, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...
22nd Century Group (XXII) Announces Production of VLN® Homogenized Tobacco Leaf Sheet
23. Juni 2023 09:00 ET
|
22nd Century Group, Inc
HTL Is Commonly Used in Heat-Not-Burn and Cigar Binder and Wrapper Applications Provides VLN® Tobacco Solution in Large Adjacent Markets BUFFALO, N.Y., June 23, 2023 (GLOBE NEWSWIRE) -- 22nd...
VLN® Products Launch in Nevada to Help Smokers Smoke Less
21. Juni 2023 09:00 ET
|
22nd Century Group, Inc
Terrible Herbst and Speedee Mart Selling VLN® Reduced Nicotine Products in Approximately 200 Las Vegas Area Stores FDA Authorized VLN® Products Are Specifically Designed to Reduce the Harms of...
22nd Century Announces $5.3 Million Registered Direct Offering Priced Above Market
20. Juni 2023 07:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., June 20, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...
22nd Century Group (XXII) Launching VLN® at #1 U.S. C-Store Chain in Texas, California and Florida
06. Juni 2023 09:00 ET
|
22nd Century Group, Inc
Largest U.S. C-Store Chain Will Add VLN® to More Than 1,450 Corporate Stores in Three Largest State Markets, Incentivizes Additional 3,100 Franchise Stores to Join the Launch Full Support from...
22nd Century Group (XXII) Announces Participation in the LD Micro Invitational XIII
02. Juni 2023 08:30 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., June 02, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...
22nd Century Group (XXII) Highlights Recent TCORS Symposium Findings
25. Mai 2023 09:00 ET
|
22nd Century Group, Inc
FDA Authorized VLN® Products from 22nd Century Group Provide Key Support to Menthol Ban and Reduced Nicotine Content Policies Currently Advancing in the U.S. Decades of Clinical Research Affirm the...
22nd Century Group (Nasdaq: XXII) Reports First Quarter 2023 Financial Results, Introduces 2023 Full Year Revenue Outlook
09. Mai 2023 06:00 ET
|
22nd Century Group, Inc
Readying Q2 VLN® Commercial Sales in California, Texas and Florida, Booking Additional Launches Targeting 18 States Throughout 2023Advancing VLN® Pilot Programs in Switzerland, Japan, and South...
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2023 Results on May 9, 2023
03. Mai 2023 09:15 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., May 03, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...